Epidemiology and prevention
A74 - A94
- A74: The use and misuse of behaviour change theory in dietary interventions for cancer: a systematic review
- A75: Health economic evaluation of endoscopic screening strategies for esophageal cancer in high risk areas of China
- A76: Developing resources to support GPs and practice nurses in cervical screening and HPV: Preliminary results from the Athens study
- A77: Associations between deprivation and colorectal cancer incidence and mortality in Scotland
- A78: Breast cancer screening uptake in ethnic groups in London
- A79: Hormone receptor status and ethnicity in women with breast cancer in North East London
- A80: Lifestyle factors and malignant progression in Barrett’s oesophagus: a population-based study
- A81: Attitudes of women and mothers towards HPV vaccination in Ireland: findings from a national population survey
- A82: Psychological outcomes of ovarian cancer screening in women at increased genetic risk
- A83: Health beliefs and preferences for dietary and physical activity interventions of colorectal cancer survivors - results of a questionnaire survey
- A84: The high prevalence of low vitamin D levels in breast cancer
- A85: The influence of tobacco marketing on adolescent smoking intentions via normative beliefs
- A86: BRCA2 is a moderate penetrance gene contributing to young onset prostate cancer
- A87: Rare skin cancer in England
- A88: Associations of circulating 25-hydroxyvitamin D with prostate cancer diagnosis, stage and grade
- A89: Seasonality of birth in cancer amongst 15-24 year olds in England, 1996-2005
- A90: Does the incidence of primary liver cancer vary between ethnic groups in England?
- A91: Diagnostic intervals in breast, colorectal, lung, pancreatic, oesophageal and gastric cancers 2001-2 and 2007-8: database study
- A92: Aspirin and other NSAID use and colorectal cancer survival, a study using the GPRD
- A93: Increasing rates of cervical cancer in young women in England: An analysis of national data 1982 – 2006
- A94: Identification of men with a genetic predisposition to prostate cancer: targeted screening of BRCA1/2 mutation carriers and controls. The IMPACT study